Human VEGFR3/Flt-4 Antibody Summary
Tyr25-Ile776
Accession # P35916
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
![VEGFR3/Flt-4 antibody in Human Cervical Squamous Metaplasia by Immunohistochemistry (IHC-P). VEGFR3/Flt-4 antibody in Human Cervical Squamous Metaplasia by Immunohistochemistry (IHC-P).](https://aeroglobalimagesuat.blob.core.windows.net/images/datasheets/antibody/VEGF_R3_AF349_Immunohistochemistry_7170.jpg)
VEGFR3/Flt‑4 in Human Cervical Squamous Metaplasia. VEGFR3/Flt-4 was detected in immersion fixed paraffin-embedded sections of human cervical squamous metaplasia using Human VEGFR3/Flt-4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF349) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: VEGFR3/Flt-4
VEGFR2 (KDR/Flk-1), VEGFR1 (Flt-1) and VEGFR3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domains and kinase insert domains in their intracellular regions. The expression of VEGFR1, 2, and 3 is almost exclusively restricted to the endothelial cells. These receptors are likely to play essential roles in vasculogenesis and angiogenesis.
VEGFR3 cDNA encodes a 1298 amino acid (aa) residue precursor protein with a 24 aa residue signal peptide. Mature VEGFR3 is composed of a 751 aa residue extracellular domain, a 22 aa residue transmembrane domain and a 482 aa residue cytoplasmic domain. Both VEGF-C and VEGF-D have been shown to bind and activate VEGFR3 (Flt-4). VEGFR3 is widely expressed in the early embryo but becomes restricted to lymphatic endothelia at later stages of development. It is likely that VEGFR3 may be important for lymph angiogenesis.
Product Datasheets
Citations for Human VEGFR3/Flt-4 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
19
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Fibroblasts facilitate lymphatic vessel formation in transplanted heart
Authors: Gong, H;Wang, T;Sun, X;Zhang, Y;Qiu, Y;Sun, W;Zhang, Y;Teng, P;Hu, Y;Hu, X;Ma, L;Xu, Q;Zhao, H;
Theranostics
Species: Murine polyomavirus strain A3, Viral
Sample Types: Cell Lysates, Whole Tissue
Applications: Immunohistochemistry, Western Blot -
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema
Authors: Creff, J;Lamaa, A;Benuzzi, E;Balzan, E;Pujol, F;Draia-Nicolau, T;Nougué, M;Verdu, L;Morfoisse, F;Lacazette, E;Valet, P;Chaput, B;Gross, F;Gayon, R;Bouillé, P;Malloizel-Delaunay, J;Bura-Rivière, A;Prats, AC;Garmy-Susini, B;
EMBO molecular medicine
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis
Authors: A Das, D Ash, AY Fouda, V Sudhahar, YM Kim, Y Hou, FZ Hudson, BK Stansfield, RB Caldwell, M McMenamin, R Littlejohn, H Su, MR Regan, BJ Merrill, LB Poole, JH Kaplan, T Fukai, M Ushio-Fuka
Nature Cell Biology, 2022-01-13;24(1):35-50.
Species: Human
Sample Types: Cell Lysates
Applications: Immunoprecipitation -
REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression
Authors: M Park, J Kim, T Kim, S Kim, W Park, KS Ha, SH Cho, MH Won, JH Lee, YG Kwon, YM Kim
Experimental & Molecular Medicine, 2021-10-25;0(0):.
Species: Human
Sample Types: Cell Lysate
Applications: Western Blot -
Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies
Authors: BR Thomson, P Liu, T Onay, J Du, SW Tompson, S Misener, RR Purohit, TL Young, J Jin, SE Quaggin
Nature Communications, 2021-10-18;12(1):6072.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients
Authors: P Ella-Tongw, RM Lamb, A Makanga, I Shergill, SF Hughes
BMC Urol, 2020-11-25;20(1):187.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4
Authors: LD Volk-Drape, KL Hall, AC Wilber, S Ran
PLoS ONE, 2017-06-09;12(6):e0179257.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry, ICC -
VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling
Authors: K Heinolaine, S Karaman, G D'Amico, T Tammela, R Sormunen, L Eklund, K Alitalo, G Zarkada
Circ. Res, 2017-03-15;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction
Authors: Tom J Parry
Eur. J. Pharmacol, 2016-12-16;796(0):76-89.
Species: Human
Sample Types: Recombinant Protein
Applications: Western Blot -
Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance
Authors: Masaaki Miyazawa
J. Exp. Med., 2016-11-04;0(0):.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr -
TGF-?1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)
PLoS ONE, 2016-09-02;11(9):e0162221.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma.
Authors: Wakisaka N, Hasegawa Y, Yoshimoto S, Miura K, Shiotani A, Yokoyama J, Sugasawa M, Moriyama-Kita M, Endo K, Yoshizaki T
PLoS ONE, 2015-12-02;10(12):e0144056.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Lymphatic endothelial cells support tumor growth in breast cancer.
Authors: Lee, Esak, Pandey, Niranjan, Popel, Aleksand
Sci Rep, 2014-07-28;4(0):5853.
Species: Human
Sample Types: Cell Culture Supernates
Applications: IHC -
Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma.
Authors: Omoto, Itaru, Matsumoto, Masataka, Okumura, Hiroshi, Uchikado, Yasuto, Setoyama, Tetsuro, Kita, Yoshiaki, Owaki, Tetsuhir, Kijima, Yuko, Shinchi, Hiroyuki, Ishigami, Sumiya, Ueno, Shinichi, Natsugoe, Shoji
Oncol Lett, 2014-01-24;7(4):1027-1032.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.
Authors: Thelen A, Scholz A, Benckert C, Von Marschall Z, Schroder M, Wiedenmann B, Neuhaus P, Rosewicz S, Jonas S
Int. J. Cancer, 2008-06-01;122(11):2471-81.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Authors: Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E
Leuk. Res., 2004-03-01;28(3):243-8.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
Authors: Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML
Cancer Res., 2004-01-15;64(2):554-64.
Species: Human
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC-P, Western Blot -
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
Authors: Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS
Int. J. Cancer, 2003-05-01;104(5):603-10.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: ICC, Immunoprecipitation, Western Blot -
Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
Authors: Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK
Clin. Cancer Res., 2003-04-01;9(4):1361-9.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human VEGFR3/Flt-4 Antibody
There are currently no reviews for this product. Be the first to review Human VEGFR3/Flt-4 Antibody and earn rewards!
Have you used Human VEGFR3/Flt-4 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image